March 31,

September 30,

2026

2025

(in thousands)

Accrued payroll and related expenses

$

2,936

$

6,469

Accrued research and development expenses

1,204

1,800

Accrued professional fees

911

1,386

Accrued pharmaceutical drug manufacturing

1,498

2,691

Accrued other

310

405

$

6,859

$

12,751